Zoetis Inc. $ZTS Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB decreased its position in shares of Zoetis Inc. (NYSE:ZTS) by 3.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 198,407 shares of the company’s stock after selling 6,233 shares during the period. Handelsbanken Fonder AB’s holdings in Zoetis were worth $29,031,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Andra AP fonden lifted its stake in Zoetis by 136.9% during the third quarter. Andra AP fonden now owns 268,200 shares of the company’s stock valued at $39,243,000 after purchasing an additional 155,000 shares during the last quarter. Hikari Tsushin Inc. raised its position in Zoetis by 450.0% during the third quarter. Hikari Tsushin Inc. now owns 41,494 shares of the company’s stock valued at $6,071,000 after buying an additional 33,950 shares during the period. Artisan Partners Limited Partnership lifted its position in shares of Zoetis by 35.1% in the third quarter. Artisan Partners Limited Partnership now owns 1,004,211 shares of the company’s stock worth $146,936,000 after purchasing an additional 260,909 shares in the last quarter. R Squared Ltd lifted its position in Zoetis by 143.7% in the 3rd quarter. R Squared Ltd now owns 3,509 shares of the company’s stock worth $513,000 after buying an additional 2,069 shares in the last quarter. Finally, Diversify Wealth Management LLC boosted its position in Zoetis by 4.4% during the third quarter. Diversify Wealth Management LLC now owns 34,997 shares of the company’s stock valued at $5,052,000 after purchasing an additional 1,461 shares during the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. BTIG Research reiterated a “buy” rating and issued a $160.00 target price on shares of Zoetis in a research note on Thursday. KeyCorp began coverage on Zoetis in a research note on Thursday, November 20th. They set a “sector weight” rating for the company. Stifel Nicolaus decreased their price target on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a research report on Tuesday, November 18th. UBS Group set a $136.00 price objective on Zoetis in a report on Thursday, January 29th. Finally, The Goldman Sachs Group raised shares of Zoetis to a “buy” rating in a research note on Monday, December 15th. Five research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $152.91.

Zoetis Stock Performance

ZTS stock opened at $131.06 on Friday. The company has a debt-to-equity ratio of 2.71, a current ratio of 3.03 and a quick ratio of 1.94. Zoetis Inc. has a fifty-two week low of $115.25 and a fifty-two week high of $177.00. The stock has a market capitalization of $55.32 billion, a PE ratio of 21.77, a price-to-earnings-growth ratio of 1.98 and a beta of 0.96. The company has a 50 day moving average price of $126.05 and a 200 day moving average price of $134.15.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.08. The firm had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The company’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be given a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Monday, April 20th. Zoetis’s dividend payout ratio (DPR) is currently 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.